ABSTRACT: Two major populations of dendritic cells (DCs), myeloid and plasmacytoid, can be isolated from human peripheral blood, and are distinguished by differential expression of the cell surface markers CD11c and CD123. These two populations of DCs also are different in their expression of Toll-like receptor (TLRs), which are involved in their activation. To investigate the early events during activation of peripheral DCs, the cells were stimulated in vitro with ligands for TLR-4 (as in lipopolysaccharides [LPS]) or TLR-9 (CpG-containing oligonucleotide [CpG]). The earliest change in protein expression detected after stimulating peripheral DCs with lipopolysaccharide (LPS) or CpG was increased production of the chemokine interleukin (IL)-8. Enhanced production of IL-8 occurred already within 2 hours of stimulation in both myeloid dendritic cells (M-DCs) and plasmacytoid dendritic cells (P-DCs), and preceded expression of the well established activation marker CD40. Although both populations of DCs secreted IL-8 upon activation, the levels of IL-8 produced was several times higher within the M-DCs compared with the P-DCs population. Before activation, both subsets of DCs expressed the IL-8 receptor type B (CD128b); but after stimulation the IL-8 receptor was down-regulated in both populations of DCs. Increased expression of MHC class II molecules is generally regarded as an early activation marker of DCs. However, only the P-DCs showed a significant up-regulation of MHC class II after stimulation. The M-DC population up-regulated MHC class II without any prior activation; thus care should be taken using increased expression of MHC class II molecules as an early activation marker of peripheral M-DCs after activation in vitro.
INTRODUCTION
Dendritic cells (DCs) play a central role in our immune system [1] . The DCs are the most important cell type responsible for antigen presentation, and as such they control both initiation and maintenance of adaptive immune responses, as well as induction of peripheral tolerance [2] [3] [4] [5] .
Immature DCs are normally found in peripheral blood. Upon activation these cells will up-regulate surface molecules such as MHC class II, adhesion and co-stimulatory molecules, thereby adopting a mature phenotype [6] . The DCs sample and sense their environment and pass this information on to the immune system. When pathogenic organisms or substances are encountered, the presence of non-self material will immediately be communicated to the immune system. Pathogens are primarily recognized by a large number of pathogen-associated molecular patterns (PAMPs) that are identified by conserved pattern recognition receptors (PRRs), such as the Toll-like receptors (TLRs) [7] . Several TLRs have been identified and proven to be crititically involved in provoking maturation of DCs [8, 9] .
In addition, TLRs are also differentially expressed on diverse DC subsets [9, 10] . For example, in human peripheral blood, the two major subpopulations of DCs, the myeloid (M-DCs) and the plasmacytoid (P-DCs) dendritic cells, differently express TLR4 and TLR9 [9, 10] . The initial phenotypic changes that occur after DC activation are important and interesting to study to gain insight in the regulation of our immune system. However, the early events after myeloid and plasmacytoid DC activation remain relatively unknown. Here, we describe some early activation events at the protein level after in vitro stimulation of DCs using ligands to TLRs.
MATERIALS AND METHODS Cells and Reagents
Peripheral blood buffy coat preparations were obtained from the Blood Bank of the University Hospital of Malmoe (Sweden). Blood dendritic isolation kit II (MACS), LD and MS columns were from Miltenyi Biotec, Bergisch Gladbach, Germany.
Lipopolysaccharide (LPS, from Escherichia coli O111:B4) was from Sigma (St. Louis, MO). The CpG oligodeoxynucleotide (ODN) sequences, 5=-tcgtcgttttgtcgttttgtcgtt-3= and 5=-ggGGGACGATCGTCgggggg3=, phosphorothioate (PTO) linkages between the bases are shown in lower case and phosphodiester linkages are shown in capital letters, were obtained from MWG-BIOTECH AG (Ebersberg, Germany). The ODNs were suspended in sterile dH 2 0 and stored and handled under aseptic conditions. A Limulus Amebocyte Lysate (LAL) kit (Charles River Endosafe, Charles River Laboratories, Inc., Charleston, SC) was used to determine the amount of endotoxin in the CpG preparation and was shown to be, in 5 g/ml solution of CpG, below detection limit of the assay (0.5 ng LPS/ml).
N-hydroxysuccinimide biotin (NHS-biotin) was purchased from Bio-Rad Laboratories (Richmond, CA). RPMI 1640 with L-glutamine, gentamicin, Dulbecco's PBS without Ca 2ϩ and Mg 2ϩ and human serum "off the clot" Type AB, were all purchased from PAA Laboratories (Linz, Austria). Ficoll-Paque was purchased from Amersham Pharmacia Biotech AB (Uppsala, Sweden). Fragmin was obtained from Pfizer (Täby, Sweden). Human IgG (h-IgG) (Gammanorm) was purchased from Biovitrum AB (Stockholm, Sweden).
The BD Cytofix/Cytoperm Plus (with GolgiStop) cytokine intracellular staining, Cytometric Bead Array (CBA) human inflammation kit, Annexin V-FITC Apoptosis detection Kit I and 7-Amino-Actinomycin D (7-AAD) were all purchased from Becton Dickinson (San Diego, CA).
Isolation of Human Peripheral Blood Dendritic Cells
Peripheral blood mononuclear cells (PBMCs) were separated using peripheral blood buffy coat preparations from healthy donors by density-gradient centrifugation on Ficoll-Paque [11] with added Fragmin (20 units/ml).
Isolation of human peripheral DCs was performed by a two-step procedure using the human blood dendritic cell isolation kit II (MACS) using LD and MS columns following the manufacturer's instructions. Briefly, PBMC were incubated with non-DC depletion cocktail (containing biotin labeled anti BDCA-1 and microbeads conjugated with monoclonal antibodies against human CD14 and CD19) in PBS containing 0.5% bovine serum albumin (BSA) and 2 mmol/L EDTA for 15 minutes at 4°C, washed and applied on a MACS column. The flow through fraction containing pre-enriched DCs, were incubated with DC enrichment cocktail (microbeads conjugated with antibodies against biotin, human BDCA-4 and BDCA-3) in PBS containing 0.5% BSA and 2 mmol/L EDTA for 15 minutes at 4°C and washed once. Labeled dendritic cells were adsorbed on a MACS column and eluted after removal of the column from the magnetic device. To achieve highest purity of the DC population, the positively selected cells were after elution, separated over a second MACS column as a standard procedure.
In Vitro Stimulation of Isolated Peripheral Blood Dendritic Cell Preparations
Cells were suspended in culture medium; RPMI 1640 supplemented with 10% human serum "off the clot," Type AB, and 100 g/ml of gentamicin. Isolated dendritic cells were incubated at a final concentration of 1 ϫ 10 6 /ml in Eppendorf tubes rotated with short rotation intervals using a Triomix-rotator (Triolab AB, Sweden) in the presence or absence of LPS 1 g/ml or CpG 5 g/ml.
The CpG sequences used in this study were 5=-tcgtcgttttgtcgttttgtcgtt-3=, which corresponds to the B-class ODN-2006 [12] and 5=-ggGGGACGATCGTCgggggg3=, which corresponds to the A-class ODN 2216 [13] , both used in previous studies. The CpG sequence of the B-class was used throughout in this paper except in experiments inducing production of ␣-interferon where the CpG sequence of the A-class was used. All cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 for up to 8 hours. Stimulated or un-stimulated isolated dendritic cells were upon end of incubation tested for signs of necrosis or apoptosis using 7-AAD and Annexin-FITC. Briefly, according to the manufacturer's instruction, cells, final concentration 1 ϫ 10 6 /ml, were washed twice in cold PBS and resuspended in 1 ϫ binding buffer, 5 l Hybridomas producing antibodies against human MHC class I (Hb149) and MHC class II (Hb104) were obtained from ATCC/LGC-Promochem (Teddington, United Kingdom). After purification of the antibodies by proteinG-Sepharose, the antibodies were labeled with N-hydroxysuccinimidebiotin [14] .
Streptavidin-peridinin chlorophyll-a protein conjugate (SAV-PerCP) was purchased from Becton Dickinson (San Diego, CA).
Briefly, after incubation at 37°C or on ice, cells (1 ϫ 10 5 to 2 ϫ 10 5 ) were washed with 1 ml PBS containing 0.1% (w/v) BSA (PBS-BSA), re-suspended in 100 l PBS containing 0.1% (w/v) BSA and 0.1% (w/v) h-IgG (PBS-BSA-hIgG) and stained with fluorescent labeled primary antibodies for 30 minutes on ice in the dark. Finally the samples were washed with 1 ml PBS-BSA, re-suspended in 500 l of PBS-BSA and analyzed by flow cytometry.
After incubation with biotin labeled antibodies the cells were washed with 1 ml PBS-BSA, re-suspended in 100 l of PBS-BSA-hIgG containing SAV-PerCP, final dilution 1:400 and incubated for 30 minutes on ice in the dark. Finally the samples were washed with 1 ml PBS-BSA, re-suspended in 500 l of PBS-BSA and analyzed by flow cytometry.
For intracellular staining, cells were stained for cell surface antigens, before the intracellular staining procedure. Briefly, cells (1 ϫ 10 6 /ml, final concentration) in medium or stimulated with LPS or CpG were incubated for 2, 4, 6, or 8 hours. To accumulate intracellular IL-8, GolgiStop was added to the cell incubations in a final dilution of 1:1500 2 hours before harvesting the cells and staining with antibodies. After harvesting, the cells (1 ϫ 10 5 to 2 ϫ 10 5 ) were washed with PBS-BSA-hIgG, stained with fluorescent labeled antibodies against CD11c and CD123, permeabilized and fixed according to the manufacturers instructions (Becton Dickinson, San Diego, CA). Finally the cells were stained with PE conjugated antibodies against IL-8 at a final concentration of 0.5 g/ml (G265-8, Becton Dickinson) and analyzed by flow cytometry.
Intracellular IL-8 receptor type B (CD128b) was analyzed 4 hours after incubation with LPS or CpG 37°C. As a control, cells were incubated in medium at 37°C and at 4°C. The cells were harvested, washed, stained for surface expression of CD11c and CD123, permeabilized, and fixed. Finally the cells were stained for intracellular CD128b and analyzed by flow cytometry.
Cells were analyzed by FACScan using standard settings and CELLQuest version 3.3 (Becton Dickinson).
Detection of Secreted Cytokines
Cytokine content in the medium after stimulation with CpG of the class B or LPS was assayed using the Cytometric Bead Array (CBA) human inflammation kit from BD Pharmingen/Becton Dickinson. Briefly, cell culture (1 ϫ 10 6 /ml, final concentration) medium supernatants were collected upon end of an incubation period and stored at Ϫ20°C. The concentration of IL-8, IL-1␤, IL-6, IL-10, TNF-␣, and IL-12p70 were then determined in the supernatants (50 l) according to the manufacturer's instruction using a FACScan flow cytometer and BD Software (Becton Dickinson).
The content of ␣-interferon was determined by an enzyme-linked immunosorbent assay kit purchased from PBL Biomedical Laboratories (Piscataway, NJ). In brief, collected supernatants (100 l in duplicates and stored at Ϫ20°C) from CpG-conditioned cell culture medium (1 ϫ 10 6 /ml, final concentration) after 8 or 16 hours of stimulation were analyzed for ␣-interferon using a human interferon-␣ enzyme linked immunosorbent assay kit according to the manufacturer's instruction. Results were analyzed with KC-Junior Software version 1.41.4 (Bio-tek Instruments, Winooski, Vermont).
In Vitro Activation of DCs Before Isolation From PBMCs
The PBMCs were suspended in culture medium. A 60-ml quantity of PBMCs at a final concentration of 1 ϫ 10 7 /ml was incubated 4 hours in two 50-ml tubes in the presence or absence of LPS 10 g/ml in a humidified atmosphere containing 5% CO 2 for 4 hours at 37°C. During incubation the tubes were rotated using a MACS mix (Mx001, Miltenyi Biotec, Bergisch Gladbach, Ger-many). Upon end of incubation dendritic cells were isolated using the human blood dendritic cell isolation kit II (MACS) as previously described. Expression of CD40, MHC class II and intracellular accumulation of IL-8 by the isolated DCs were then analyzed by flow cytometry. For intracellular staining, cells were washed ones with PBS containing 0.1% (w/v) BSA (PBS-BSA) and then re-suspended in culture medium containing GolgiStop (final dilution of 1:1500) and left to incubate for 2 hours at 37°C in a humidified atmosphere containing 5% CO 2 , before intracellular staining of IL-8 was performed. Before the intracellular staining procedure cells were stained with antibodies against CD11c and CD123 to identify the DC populations.
RESULTS
As previously described, after isolating DCs from human peripheral blood, two major populations of DCs could be identified. The preparations of DCs showed on average 56 Ϯ 13% CD11c ϩ and 36 Ϯ 10% CD123 ϩ dendritic cells (n ϭ 10) and these cells correspond to myeloid and plasmacytoid DC based on the differential expression of the CD markers CD11c (M-DCs) and CD123 (P-DCs) [4] . The M-DC and the P-DC populations showed the phenotype CD4 (Table 1) , and it should also be stressed that in accordance with Tomoki et al. [13] a clear difference between CpG of the A and B class was observed. Very low production of ␣-interferon was obtained after stimulation with CpG of the B class whereas the A class induced very low up-regulation of the co-stimulatory molecules CD40, CD80, and CD86.
The two subpopulations of human peripheral DCs have been shown to differentially express TLRs important for the activation of DCs. The M-DC population express TLR-4 while the P-DCs express TLR-9 [9, 10] .
To follow the early activation in peripheral DCs, the cells were stimulated in vitro with ligands for TLR-4 (LPS) or TLR-9 (CpG). As expected, the stimulation with LPS and CpG induced up-regulation of CD40, CD86 and CD80 in myeloid and plasmacytoid DCs, respectively. Expression of CD40 was used to verify activation of the DC populations (Figures 1 and 2 ) and was clearly upregulated in the P-DC population after stimulation with CpG. No or almost no up-regulation of CD40 in the P-DC population was observed with LPS ( Figure 2A) . Although the M-DC population has not been reported to express TLR-9 [8] , there was an unexpected upregulation of CD40 after incubation with CpG in the M-DCs population ( Figure 2B ) However, compared with stimulation with LPS, the up-regulation of CD40 was delayed by approximately 2 hours after incubation with CpG ( Figure 2B) .
Activation of peripheral DCs with LPS or CpG of the B-class also resulted in production of several cytokines Abbreviations: CpG ϭ CpG-containing oligonucleotide. Purified dendritic cells (DCs) (1 ϫ 10 6 /ml, final concentration) were stimulated with 5 g CpG /ml. After 16 hours at 37°C the cells were removed and the content of ␣-interferon in the medium was analyzed.
( Table 2) . TNF-␣, IL-1b, IL-6, IL-8, IL-10, and IL12p70 were analyzed and both LPS and CpG induced secretion of TNF-␣, IL-6, and high amounts of IL-8. An almost identical secretion of IL-6 was obtained by both PAMPs and compared with stimulation using CpG, stimulation with LPS resulted in higher production of IL-8. On the other hand, stimulation with CpG caused a clearly enhanced production of TNF-␣, compared with LPS (Table 2 ).
Incubation with LPS or CpG of the B-class rapidly induced production of IL-8. The cellular production of IL-8 was analyzed by intracellular staining of the DC populations. Depending on the type of stimuli used, a clear difference between the M-DCs and the P-DCs in the amount of intracellular IL-8 accumulated was observed ( Figure 3) . The kinetic production of IL-8 by the two DC populations was investigated by arresting the secretion of IL-8 using GolgiStop for 2 hours at various times after activation. The P-DCs responded only to stimulation with CpG and after 4 hours a maximal production of IL-8 was reached ( Figure 4A ). The M-DCs produced IL-8 after stimulation with both of LPS or CpG ( Figure 4B) . However, the production of IL-8 after incubation with CpG, was delayed by 2 hours, similar to the delayed expression of CD40 as described above (Figures 2B and 4B ). Almost all of the M-DCs produced IL-8 (80%-90% of the cells) after stimulation with LPS, whereas only 40%-50% of the P-DCs produced IL-8 after incubation with CpG.
Before activation with LPS or CpG both subsets of DCs weakly expressed the IL-8 receptor type B (CD128b). However, upon stimulation, the IL-8 receptor was down-regulated and became undetectable in P-DCs and mearly detectable in M-DCs ( Figure 5 ). Intracellular staining of non-stimulated and stimulated DCs was also performed, but the IL-8 receptor could not be detected intracellular in either DC population.
Increased surface expression of MHC class II are generally regarded as an early activation marker of DCs. Stimulation of the P-DCs with CpG of the B class induced a clearly higher up-regulation of MHC class II compared with stimulation by LPS ( Figure 6A ). Surprisingly, the M-DC population rapidly up-regulated MHC
FIGURE 2 CD40
ϩ DCs after activation. Cells incubated in culture medium were stimulated with LPS () or CpG (□) for up to 8 hours at 37°C. At 2-hour intervals samples were withdrawn, the cells were harvested, washed and stained with antibodies against CD11c, CD123, and CD40. The CD40 Abbreviations: CpG ϭ CpG-containing oligonucleotide; LPS ϭ lipopolysaccharide; IL ϭ interleukin; TNF ϭ tumor necrosis factor. Purified dendritic cells (1 ϫ 10 6 /ml, final concentration) were stimulated with 1 g LPS/ml or 5 g CpG /ml. After the indicated time points at 37°C the cells were removed and the cytokine content in the medium was analyzed. The presence of TNF-␣, IL-1b, IL-6, IL-8, IL-10, and IL-12p70 were assayed. The cytokine concentration as pg/ml of one representative experiment of three is shown. a IL-1b, IL-10, and IL-12p70, were analyzed and not detected.
class II after conditioning in medium at 37°C. This up-regulation was almost identical to the up-regulation after stimulation with PAMPs ( Figure 6B and Table 3) . No up-regulation of MHC class II was observed within the P-DCs population after conditioning in medium and no significant up-regulation of MHC class I was observed in either of the DC populations ( Figure 6A and Table 3 ).
To verify our observed early activation events of DCs in the presence of other cells, PBMCs were stimulated with LPS for 4 hours before DCs were isolated using magnetic separation (MACS). DCs isolated from PBMCs stimulated with LPS showed the same activation markers as seen after stimulation of purified DCs. Briefly, upregulation of CD40 and high level of intracellular IL-8 by the M-DC population. The expression of MHC class II was equal to what was observed on M-DCs isolated from PBMCs incubated in control medium, confirming an early MHC-II expression independent of PAMP stimulation by the M-DC population.
DISCUSSION
The early events after peripheral DC activation are not well investigated. Plasticity and crossregulation during DC maturation events makes it important to understand and then in the future be able to regulate these events so that the final effector function of the dendritic cells can be controlled. This could perhaps generate more effective vaccines for treating infectious diseases or controlling and maintaining immune tolerance, or even providing us with effective methods for treating tumours.
Stimulation of purified peripheral DCs by CpG or LPS resulted in an up-regulation of the co-stimulatory molecules CD40 (Figures 1 and 2 ), CD86 and CD80 (data not shown). CD40 was the earliest up-regulated costimulatory molecule and was used to verify activation of the DC populations. LPS and CpG involve pathogenassociated molecular patterns and mediate activation of DCs by binding to different TLRs expressed by the DCs. Up-regulation of co-stimulatory molecules on P-DCs after stimulation with CpG, and on M-DCs after stimulation with LPS was expected and correspond well with the reported expression of TLR-9 by P-DCs and TLR-4 by M-DCs [9, 10] . Although some reports have indicated no or low expression of TLR-4 by M-DCs [15] , our results showed that there is a clear up-regulation of co-stimulatory molecules after stimulation with LPS within this population.
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P-DCs has not been reported to express TLR-4 [10] . In the presence of LPS, a weak up-regulation of co-stimulatory molecules by the P-DCs was obtained (Figure 2A) . However, this up-regulation was similar when the P-DCs were incubated in medium (data not shown), suggesting that LPS does not induce activation of these cells.
Similarly, M-DCs have not been shown to express TLR-9 [8] . However, the cells showed a clear up-regulation of co-stimulatory molecules after incubating the purified DC preparation with CpG ( Figure 2B) . Stimulation of the DCs with CpG resulted in a slower kinetic expression of CD40 by the M-DC population compared with the P-DCs, and the M-DCs after stimulation with LPS ( Figure 2 ).
Activation of P-DCs through TLR-9 induced secretion of TNF-␣ into the medium that was detected already after 2 hours of stimulation ( Table 2 ). The M-DC population express TNF-␣ receptors of the type TNF-␣RII [16] , and TNF-␣ released by activated P-DCs may stimulate and activate the M-DC population. This could explain the observed up-regulation of co-stimulatory molecules by the M-DC population after stimulation with CpG and also their slower kinetic expression of CD40. Production of IL-8 by activated DCs has been reported earlier [17, 18] , and a major release of IL-8 into the medium was observed after stimulation of purified DCs with CpG or LPS ( Table 2) . Although both PAMPs induced high amounts of IL-8 in the medium, LPS induced much more IL-8 than did CpG. Intracellular staining of IL-8 revealed 80%-90% of the M-DCs to produce IL-8 after activation with LPS whereas only 40%-50% of the P-DCs produced IL-8 after activation with CpG (Figure 4) . Although the preparations of DCs contained a lower amount of P-DCs compared with M-DCs , the reduced number of P-DCs producing IL-8 is probably the major explanation of the lower amount of IL-8 detected in the medium after stimulation with CpG.
Intracellular staining for IL-8 was performed on cells after accumulation of produced IL-8 during a period of 2 hours at various times after activation. The highest number of DCs producing IL-8 was seen after 4 hours of activation for both M-DCs and P-DCs. However, the number of P-DCs producing IL-8 peaked after 4 hours of activation ( Figure 4A ), whereas the M-DCs showed a more or less steady state in the number of cells producing IL-8 already after 4 hours of activation ( Figure 4B ).
PAMP induced production of IL-8 showed a faster kinetic rate than the corresponding up-regulation of co-stimulatory molecules and was observed already after 2 hours of stimulation with CpG or LPS (Figure 4) . TLR-4 is expressed both intracellular and in the cell 1.38 Ϯ 0.34 (n ϭ 7)
Abbreviations: CpG ϭ CpG-containing oligonucleotide; DC ϭ dendritic cell; LPS ϭ lipopolysaccharide; MFI ϭ mean fluorescence intensity.
Results are presented as mean Ϯ SD. Myeloid and plasmacytoid dendritic cells (DC) were identified by flow cytometry using antibodies against CD11c and CD123. Expression of MHC class I and class II by M-DCs and P-DCs were analysed and the mean fluorescence intensity (MFI) of the cell populations were determined. MFI values were determined after; incubation in medium, stimulation with 1 g LPS/ml or stimulation with 5 g CpG/ml. The MFI ratios were calculated between cells incubated at 37°C for 4 hours and cells incubated in medium at 4°C.
